Description

Tripeptidyl aminopeptidase (Cerliponase alfa) removes tripeptides from the free NH, terminus of longer peptides. Tripeptidyl aminopeptidase has the potential for the research of CLN2 disease[1][2].–Applications-Neuroscience-Neuromodulation-Formula-N/A-Citation–References-[1]Schulz A, et al. Study of Intraventricular Cerliponase Alfa for CLN2 Disease. N Engl J Med. 2018 May 17;378(20):1898-1907.|[2]Bålöw RM, et al. Tripeptidyl aminopeptidase in the extralysosomal fraction of rat liver. J Biol Chem. 1983 Oct 10;258(19):11622-8.-CASNumber-151662-36-1-MolecularWeight-N/A-Compound Purity–SMILES-[Tripeptidyl aminopeptidase]-Research_Area-Neurological Disease-Solubility-10 mM in DMSO-Target-Endogenous Metabolite-Isoform–Pathway-Metabolic Enzyme/Protease-MCE Product type-Enzyme